Dr. Kate Stringaris

Dr Kate Stringaris is a Consultant Haematologist and Clinician Scientist at University College London Hospital, specialising in the treatment of blood disorders through chemotherapy, cellular therapies, and stem cell transplantation.

She obtained her medical degree from University College London and completed her general medical training at St George's Hospital. Her specialist haematology training took place at the Royal Free Hospital and Hammersmith Hospitals in London. Dr Stringaris earned a PhD in Leukaemia from Imperial College London and previously served as a Senior Clinical Lecturer at St Bart’s Hospital.

Her research focuses on immune deficiencies in leukaemia and transplantation immunology. She spent four years as a senior research physician at the National Heart, Lung, and Blood Institute, National Institutes of Health (USA), where she explored natural killer cell immunity and innovative immune therapies for acute myeloid leukaemia.

Appointed as a Consultant Haematologist in 2014, Dr Stringaris is committed to advancing haematology through clinical practice and research. Her expertise includes chemotherapy, cellular therapies, and immune therapies, particularly in the treatment of acute myeloid leukaemia and the development of novel therapies to improve patient outcomes.